333 related articles for article (PubMed ID: 28283756)
21. The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells.
Ganor Y; Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):983-1006. PubMed ID: 24584970
[TBL] [Abstract][Full Text] [Related]
22. Neuroprotective arylpiperazine dopaminergic/serotonergic ligands suppress experimental autoimmune encephalomyelitis in rats.
Popovic M; Stanojevic Z; Tosic J; Isakovic A; Paunovic V; Petricevic S; Martinovic T; Ciric D; Kravic-Stevovic T; Soskic V; Kostic-Rajacic S; Shakib K; Bumbasirevic V; Trajkovic V
J Neurochem; 2015 Oct; 135(1):125-38. PubMed ID: 26083644
[TBL] [Abstract][Full Text] [Related]
23. The peripheral dopaminergic system: morphological analysis, functional and clinical applications.
Amenta F; Ricci A; Tayebati SK; Zaccheo D
Ital J Anat Embryol; 2002; 107(3):145-67. PubMed ID: 12437142
[TBL] [Abstract][Full Text] [Related]
24. Dopamine receptors modulate T lymphocytes via inhibition of cAMP-CREB signaling pathway.
Huang Y; Chen CC; Wang TT; Qiu YH; Peng YP
Neuro Endocrinol Lett; 2016 Dec; 37(7):491-500. PubMed ID: 28326743
[TBL] [Abstract][Full Text] [Related]
25. Dopamine inhibits human CD8+ Treg function through D
Nasi G; Ahmed T; Rasini E; Fenoglio D; Marino F; Filaci G; Cosentino M
J Neuroimmunol; 2019 Jul; 332():233-241. PubMed ID: 30954278
[TBL] [Abstract][Full Text] [Related]
26. EphrinB1 and EphrinB2 regulate T cell chemotaxis and migration in experimental autoimmune encephalomyelitis and multiple sclerosis.
Luo H; Broux B; Wang X; Hu Y; Ghannam S; Jin W; Larochelle C; Prat A; Wu J
Neurobiol Dis; 2016 Jul; 91():292-306. PubMed ID: 27039370
[TBL] [Abstract][Full Text] [Related]
27. Umbilical cord-derived mesenchymal stem cells reversed the suppressive deficiency of T regulatory cells from peripheral blood of patients with multiple sclerosis in a co-culture - a preliminary study.
Yang H; Sun J; Wang F; Li Y; Bi J; Qu T
Oncotarget; 2016 Nov; 7(45):72537-72545. PubMed ID: 27705922
[TBL] [Abstract][Full Text] [Related]
28. Levels of mRNA for dopaminergic receptor D₅ in circulating lymphocytes may be associated with subsequent response to interferon-β in patients with multiple sclerosis.
Cosentino M; Zaffaroni M; Marino F
J Neuroimmunol; 2014 Dec; 277(1-2):193-6. PubMed ID: 25468276
[TBL] [Abstract][Full Text] [Related]
29. Influence of dopamine receptor gene polymorphisms on circulating T lymphocytes: A pilot study in healthy subjects.
Cosentino M; Ferrari M; Kustrimovic N; Rasini E; Marino F
Hum Immunol; 2015 Oct; 76(10):747-52. PubMed ID: 26429319
[TBL] [Abstract][Full Text] [Related]
30. Delineating the Role of Toll-Like Receptors in the Neuro-inflammation Model EAE.
Fallarino F; Gargaro M; Mondanell G; Downer EJ; Hossain MJ; Gran B
Methods Mol Biol; 2016; 1390():383-411. PubMed ID: 26803641
[TBL] [Abstract][Full Text] [Related]
31. Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks?
Cosentino M; Marino F
J Neuroimmune Pharmacol; 2013 Mar; 8(1):163-79. PubMed ID: 23074017
[TBL] [Abstract][Full Text] [Related]
32. Immunomodulatory Effects Mediated by Dopamine.
Arreola R; Alvarez-Herrera S; Pérez-Sánchez G; Becerril-Villanueva E; Cruz-Fuentes C; Flores-Gutierrez EO; Garcés-Alvarez ME; de la Cruz-Aguilera DL; Medina-Rivero E; Hurtado-Alvarado G; Quintero-Fabián S; Pavón L
J Immunol Res; 2016; 2016():3160486. PubMed ID: 27795960
[TBL] [Abstract][Full Text] [Related]
33. Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis.
De Santi L; Annunziata P; Sessa E; Bramanti P
J Neurol Sci; 2009 Dec; 287(1-2):17-26. PubMed ID: 19758606
[TBL] [Abstract][Full Text] [Related]
34. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
[TBL] [Abstract][Full Text] [Related]
35. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A
Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
[TBL] [Abstract][Full Text] [Related]
36. Cinnamon ameliorates experimental allergic encephalomyelitis in mice via regulatory T cells: implications for multiple sclerosis therapy.
Mondal S; Pahan K
PLoS One; 2015; 10(1):e0116566. PubMed ID: 25569428
[TBL] [Abstract][Full Text] [Related]
37. Dopamine exerts no acute effects on Kv1.3 in activated encephalitogenic T cells.
Strauss U; Herbrik M; Mix E; Bajorat R; Jung S; Gimsa U; Rolfs A
Neuroimmunomodulation; 2005; 12(1):45-53. PubMed ID: 15756052
[TBL] [Abstract][Full Text] [Related]
38. Safe and effective interferon-beta gene therapy for the treatment of multiple sclerosis by regulating biological activity through the design of interferon-beta-galectin-9 fusion proteins.
Hamana A; Takahashi Y; Tanioka A; Nishikawa M; Takakura Y
Int J Pharm; 2018 Jan; 536(1):310-317. PubMed ID: 29217470
[TBL] [Abstract][Full Text] [Related]
39. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.
Rouillon C; Degoulet M; Chevallier K; Abraini JH; David HN
Brain Res; 2008 Mar; 1198():44-54. PubMed ID: 18261716
[TBL] [Abstract][Full Text] [Related]
40. Interferon-β regulates dendritic cell activation and migration in experimental autoimmune encephalomyelitis.
Pennell LM; Fish EN
Immunology; 2017 Nov; 152(3):439-450. PubMed ID: 28646573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
